Keyphrases
Peptide Vaccine
74%
Poly IC
48%
T Cells
41%
CD8+ T Cells
40%
Peptide Vaccination
37%
Tumor
36%
CD4 T Cells
34%
Antitumor
32%
Antitumor Peptides
27%
Dendritic Cells
27%
Tumor Immunity
27%
Antitumor Effect
24%
Vaccination Strategy
23%
Programmed Death-ligand 1 (PD-L1)
23%
Tumor Antigen
22%
Therapeutic Vaccine
18%
Bacterial Load
18%
Cancer Peptide Vaccine
16%
Cell Expansion
13%
Oral Homeostasis
13%
Autoimmune Pathology
13%
Chronic Obstructive Pulmonary Disease
13%
Pathogenic Bacteria
13%
Cell-mediated Immune Response
13%
Cytotoxic T Lymphocytes
13%
Forced Expiratory Volume in 1 Second (FEV1)
13%
Interferon-I
13%
Differentiation Antigen
13%
Viral Infection
13%
Pharmacotherapy
13%
Immune Regulation
13%
Cancer Immunotherapy
13%
Alpha-1 Antitrypsin Deficiency
13%
Immunogenicity
13%
Route of Administration
13%
Interleukin-2
13%
CD4+ T Helper Cells
13%
T Cell Expansion
13%
Osteonecrosis of the Jaw
13%
Tumor Infiltration
13%
Melanoma
13%
Cell Tumor
13%
Effector T Cell Response
13%
Asymmetric Waveform
13%
Ion Mobility Spectrometry
13%
High Field
13%
Tumor Neoantigens
13%
Neoantigen
13%
Adoptive Therapy
13%
Adoptive Cell Therapy
13%
Immunology and Microbiology
T Cell
100%
Peptides
74%
Peptide Vaccine
71%
T-Helper Cell
44%
Cytotoxic T-Cell
32%
Tumor Vaccine
31%
Immunity
31%
Dendritic Cell
29%
Cell Expansion
27%
Cancer Immunotherapy
27%
Neoantigen
27%
Immunotherapy
26%
Cytotoxic T Cell
26%
Carboxymethylcellulose Polycytidylic Polyinosinic Acid Polylysine
22%
Polyinosinic:polycytidylic Acid
22%
Regulatory T Cell
20%
Bacterial Load
18%
Tumor Antigen
17%
DPT Vaccine
16%
CD4
16%
Interleukin 2
16%
Adoptive Immunity
15%
Epitope
15%
interferon
15%
T Helper Cell
14%
Immunogenicity
13%
Viral Disease
13%
Differentiation Antigen
13%
Jaw
13%
Homeostasis
13%
Autoimmune Disease
13%
Ion Mobility Mass Spectrometry
13%
Drug Therapy
13%
STAT5
13%
CD8
11%
Immune Response
11%
Cytokine
10%
Polylysine
9%
Chemokine
7%
Mouse Model
6%
Parenchyma
6%
TLR3
6%
Antigen Specificity
6%
Adjuvant
6%
Vascular Endothelial Cell
6%
Cell Infiltration
6%
Immune System
5%
Immune Tolerance
5%
Tumor Rejection
5%
LILRB4
5%